Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Added value of adjuvant chemotherapy in patients with node-positive pT1-2 colon cancer: a national SNAPSHOT analysis
Saved in:
| Published in: | The Oncologist |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Added value of adjuvant chemotherapy in patients with node-positive pT1-2 colon cancer: a national SNAPSHOT analysis
- A rare case of medullary carcinoma of colon: Clinical implications and role of adjuvant therapy
- Maintenance Metronomic Chemotherapy in Treatment of Metastatic Colorectal Cancer
- Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non‐Squamous Non‐Small Cell Lung Cancer: A Multicenter Retrospective Study
- The role of adjuvant radiotherapy for breast cancer patients with axillary node negative or limited nodal disease after total mastectomy, axillary nodal clearance and systemic therapy
- Adjuvant nivolumab in resected oesophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: Slovenian real-world data
- A retrospective review of outcomes in patients with node-negative stage IB cervical cancer treated with adjuvant standard pelvic field radiation versus small field pelvic field radiation